Similar articles

• CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.

  Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, Laudanna AA, Tani CM, Almeida FL, Zatz M. Bernardino AL, et al. JOP. 2003 Sep;4(5):169-77. JOP. 2003. PMID: 14526128
• Genetic factors in pancreatitis.

  Grigorescu M, Grigorescu MD. Grigorescu M, et al. Rom J Gastroenterol. 2005 Mar;14(1):53-61. Rom J Gastroenterol. 2005. PMID: 15800694 Review.
• Genetic testing in chronic pancreatitis.

  Tazelaar JP, Kant JA. Tazelaar JP, et al. Expert Rev Mol Diagn. 2003 Nov;3(6):799-809. doi: 10.1586/14737159.3.6.799. Expert Rev Mol Diagn. 2003. PMID: 14628907 Review.
• Genetic risk factors in chronic pancreatitis.

  Teich N, Ockenga J, Keim V, Mössner J. Teich N, et al. J Gastroenterol. 2002 Jan;37(1):1-9. doi: 10.1007/s535-002-8125-1. J Gastroenterol. 2002. PMID: 11824793 Review. No abstract available.
• Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).

  Teich N, Le Maréchal C, Kukor Z, Caca K, Witzigmann H, Chen JM, Tóth M, Mössner J, Keim V, Férec C, Sahin-Tóth M. Teich N, et al. Hum Mutat. 2004 Jan;23(1):22-31. doi: 10.1002/humu.10285. Hum Mutat. 2004. PMID: 14695529